Week After Januvia Patent Is Upheld, Merck Sues Over Generic
Merck has launched a suit claiming a New Jersey-based pharmaceutical company's proposed generic of the blockbuster diabetes drug Januvia infringes its patent on the treatment, less than a week after the...To view the full article, register now.
Already a subscriber? Click here to view full article